8-K: Crown Electrokinetics Faces Delisting from Nasdaq Due to Low Share Price

Crown Electrokinetics Corp. has received a delisting notice from Nasdaq due to its share price falling below the required minimum of $1.00, and the company plans to request a hearing to appeal the decision.

Summary

• Crown Electrokinetics Corp. received a notification from Nasdaq on December 19, 2024, stating that its common stock price had fallen below the $1.00 minimum bid price requirement for 30 consecutive business days.
• The company is subject to a Mandatory Panel Monitor due to a previous hearing on May 7, 2024, and a decision on July 25, 2024, which means they are not eligible for a grace period to regain compliance.
• Crown Electrokinetics has also performed multiple reverse stock splits exceeding a cumulative ratio of 250 to 1 in the past two years, further disqualifying them from a grace period.
• The company plans to request a hearing before the Nasdaq Hearings Panel to appeal the delisting notice, which will temporarily halt any further delisting actions.
• There is no guarantee that the panel will grant the company's request for continued listing or that the company will be able to meet the listing requirements during any compliance period.

Sentiment

Score: 3

Explanation: The sentiment is negative due to the delisting notice and the uncertainty surrounding the company's future on Nasdaq. The lack of a grace period and the need for a hearing further contribute to the negative outlook.

Positives

• The company is taking action by requesting a hearing to appeal the delisting notice.
• The company's stock will continue to trade on Nasdaq under the symbol CRKN pending the hearing process.

Negatives

• The company's stock price has fallen below the minimum $1.00 requirement for continued listing on Nasdaq.
• The company is not eligible for a grace period to regain compliance due to a Mandatory Panel Monitor and multiple reverse stock splits.
• There is no guarantee that the company will be able to regain compliance or that the panel will grant their request for continued listing.

Risks

• The company faces the risk of being delisted from Nasdaq if they are unable to regain compliance with the minimum bid price rule.
• There is uncertainty regarding the outcome of the hearing and whether the panel will grant the company's request for continued listing.
• The company's stock price may be negatively impacted by the delisting notice and the uncertainty surrounding its future on Nasdaq.

Future Outlook

The company plans to request a hearing to appeal the delisting notice, but there is no assurance that they will be able to regain compliance or that the panel will grant their request for continued listing.

Management Comments

• The Company expects the Company's common stock to continue to trade on Nasdaq under the symbol CRKN pending completion of the hearing process.
• Although the Company is diligently working to regain compliance with the Bid Price Rule, there can be no assurance that the Panel will grant the Company's request for continued listing or that the Company will be able to meet the continued listing requirements during any compliance period that may be granted by the Panel.

Industry Context

This announcement highlights the challenges faced by companies with low stock prices in maintaining their listing on major exchanges like Nasdaq. It is not uncommon for companies to face delisting notices when their stock price falls below the minimum threshold.

Comparison to Industry Standards

• Many companies listed on Nasdaq are required to maintain a minimum bid price of $1.00 per share to avoid delisting.
• Companies that fail to meet this requirement are often given a grace period to regain compliance, but Crown Electrokinetics is not eligible for a grace period due to a Mandatory Panel Monitor and multiple reverse stock splits.
• Other companies facing similar delisting notices have attempted to regain compliance through various means, including reverse stock splits, raising capital, or improving their financial performance.

Stakeholder Impact

• Shareholders may experience a decline in the value of their investment due to the delisting notice.
• Employees may face uncertainty regarding the company's future and their job security.
• Customers and suppliers may be concerned about the company's ability to continue operations.

Next Steps

• The company will request a hearing before the Nasdaq Hearings Panel to appeal the delisting notice.
• The company will continue to trade on Nasdaq under the symbol CRKN pending the hearing process.

Key Dates

Keywords

delisting, Nasdaq, minimum bid price, compliance, reverse stock split, hearing, CRKN, Mandatory Panel Monitor